Delivery Order SPE2DB24D2101-SPE2DB25FKNAC
Award Date 8/4/25
Potential Completion Date 8/25/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Herceptin 150 mg vials, valued at $10,681.68, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Herceptin is a critical biopharmaceutical used in cancer treatment, particularly for...
- The U.S. government has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,942,502 units of Herceptin 150 mg vials. The contract has a ceiling value of $8,835.30 and a period of performance through April 2, 2024. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense's military treatment programs and facilities. Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Herceptin 150 mg vials. The $2,650.59 firm fixed-price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen, through its Corporate Office division, will provide these critical oncology medications to support military treatment facilities and other government healthcare programs. This delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 150 mg vials of the drug Herceptin, with a ceiling value of $26,704.20 and a performance period through July 25, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Herceptin 150 mg vials, a monoclonal antibody used in cancer treatment. This firm fixed-price delivery order, valued at $2,670.42, represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 18, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,681.68 firm fixed-price contract is for the delivery of 4,567,615,883 units of Herceptin 150 mg vials. The contract has an ultimate completion date of April 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,583.08, is for the delivery of 4,568,175,562 units of the prescription drug Herceptin 150 mg vials. The contract is a firm fixed-price delivery order with a completion date of May 29, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of HERCEPTIN 150 MG VIALS. The contract is a Delivery Order with a Firm Fixed Price of $2,670.42 and a performance period extending until July 30, 2025. It was awarded on July 9, 2025 by the Defense Logistics Agency (DLA), which serves as the Defense or Civilian agency for this contract. The contract is not set aside and is open to full and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HERCEPTIN 150 MG VIALS, a prescription medication, with a ceiling value of $21,363.36 and a completion date of July 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides $7,951.77 for the delivery of 150 mg Herceptin vials. The contract is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the...